Status:
UNKNOWN
Platelet Enriched Plasma for Treatment of Interstitial Cystitis
Lead Sponsor:
Mansoura University
Conditions:
Interstitial Cystitis
Bladder Pain Syndrome
Eligibility:
FEMALE
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
A prospective randomized trial will be conducted aiming at evaluation the efficacy and safety of platelet enriched plasma for management of bladder pain syndrome .
Eligibility Criteria
Inclusion
- Patients with a diagnosis of interstitial cystitis/ Bladder painful Syndrome for more than 3 months will be enrolled
Exclusion
- Patients with Anemia, blood disorders, history of pelvic irradiation, pelvic malignancy, and active urinary tract infection unless treated, vesical stone, gynecological disorders e.g. uterine fibroid and neurological disorders will be excluded. Patients less than 18 years old will not be allowed to participate.
Key Trial Info
Start Date :
March 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04118946
Start Date
March 20 2019
End Date
September 1 2020
Last Update
October 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ahmed S EL Hefnawy
Al Mansurah, Egypt